The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer

Journal of Surgical Oncology

Volumn 104, Issue 5, 2011, Pages 530-533

  Oh, Hyeon Hwa ^a   Lee, Sang Eok ^a   Choi, In Seok ^a   Choi, Won Jun ^a   Yoon, Dae Sung ^a   Min, Hyun Sik ^a   Ra, Yu Mi ^a   Moon, Ju Ik ^a   Kang, Yun Hee ^a  

^a Konyang University College of Medicine   (South Korea)

Author keywords

gastric cancer; PET CT

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PEAK STANDARDIZED UPTAKE VALUE; PHYSICIAN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STOMACH CANCER; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80955180976     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21985     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Shin H, Jung K, Won Y:, National cancer incidence for the year 2002 in Korea. Cancer Res Treat 2007; 39: 139-149.
3. Soetikno R, Kaltenbach T, Yeh R, et al.: Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol 2005; 23: 4490-4498. (Pubitemid 46196578)
4. Lee SE, Lee JH, Ryu KW, et al.: Sentinel node mapping and skip metastases in patients with early gastric cancer. Ann Surg Oncol 2009; 16: 603-608.
5. Hyung WJ, Kim YS, Lim JS, et al.: Preoperative imaging of sentinel lymph nodes in gastric cancer using CT lymphography. Yonsei Med J 2010; 51: 407-413.
6. Lee JH, Ryu KW, Kim CG, et al.: Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol 2006; 13: 1168-1174. (Pubitemid 44440417)
7. Park SR, Kim MJ, Ryu KW, et al.: Prognostic value of preoperative clinical staging assessed by CT in resectable gastric cancer patients: A viewpoint in the era of preoperative treatment. Ann Surg 2010; 251: 428-435.
8. Rosch T:, Endosonographic staging of gastric cancer: A review of literature results. Gastrointest Endosc Clin N Am 1995; 5: 549-557.
9. Squillaci E, Manenti G, Mancino S, et al.: Staging of colon cancer: Whole-body MRI vs. whole-body PET-CT-initial clinical experience. Abdom Imaging 2008; 33: 676-688.
10. Kim SK, Kang KW, Lee JS, et al.: Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006; 33: 148-155.
11. Chen J, Cheong JH, Yun MJ, et al.: Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 2005; 103: 2383-2390. (Pubitemid 40686585)
12. Yun M, Lim JS, Noh SH, et al.: Lymph node staging of gastric cancer using (18)F-FDG PET: A comparison study with CT. J Nucl Med 2005; 46: 1582-1588. (Pubitemid 46211580)
13. Bombardieri E, Aktolun C, Baum RP, et al.: FDG-PET: Procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 2003; 30: BP115-BP124. (Pubitemid 38017443)
14. Tschmelitsch J, Weiser MR, Karpeh MS:, Modern staging in gastric cancer. Surg Oncol 2000; 9: 23-30.
15. Dassen AE, Lips DJ, Hoekstra CJ, et al.: FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol 2009; 35: 449-455.
16. Kim EY, Lee WJ, Choi D, et al.: The value of PET/CT for preoperative staging of advanced gastric cancer: Comparison with contrast-enhanced CT. Eur J Radiol 2010. DOI: 10.1016/j.ejrad.2010.02.00
17. Berger KL, Nicholson SA, Dehdashti F, et al.: FDG PET evaluation of mucinous neoplasms: Correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol 2000; 174: 1005-1008. (Pubitemid 30179992)
18. De Potter T, Flamen P, Van Cutsem E, et al.: Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 2002; 29: 525-529.
19. Wakelin SJ, Deans C, Crofts TJ, et al.: A comparison of computerised tomography, laparoscopic ultrasound and EUS in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol 2002; 41: 161-167. (Pubitemid 34164138)
20. Cheong O, Oh ST, Kim BS, et al.: Large metastatic lymph node size, especially more than 2âcm: Independent predictor of poor prognosis in node-positive gastric carcinoma. World J Surg 2008; 32: 262-266.
21. Yang QM, Kawamura T, Itoh H, et al.: Is PET-CT suitable for predicting lymph node status for gastric cancer ? Hepatogastroenterology 2008; 55: 782-785. (Pubitemid 351741548)
22. Mukai K, Ishida Y, Okajima K, et al.: Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer 2006; 9: 192-196. (Pubitemid 44426892)